Background Image
Table of Contents Table of Contents
Previous Page  644 / 658 Next Page
Information
Show Menu
Previous Page 644 / 658 Next Page
Page Background

4

Improving Label-Free Quanti cation of Plasma and Serum Proteins Using a High-Resolution Hybrid Orbitrap Mass Spectrometer

ata acquisition schemes for

d scanning window, target

n spectral acquisition. Both

s performed to increase the

100

500

in plasma matrix

targeted peptides with confident

level of protein mixture. The bars

tified out of the potential 170

Our current MS-based biomarker discovery studies employ label-free quantification of

proteomic data using MS1 extracted ion chromatograms (XIC). In our typical discovery

experiments, we get MS1 quantification at signal threshold levels as low as 1e

5

.

However, when employing powerful software such as Pinpoint software, we can verify

that some of the MS1 quantification may be false positives (demonstrated by loss of

multiple isotope peaks or isobaric contaminants).

In this study, we compare the novel real-time state modeled acquisition based MS2

quantification with full scan MS1 (XIC) based quantification (Figure 3). As a general

observation, we see that the quality of the MS1 quantification for peptides above 2

femtomoles, the number of targeted peptides we quantify with confidence, is on-par

with the MS2-based quantification. However, below 2 femtomoles, the quantity and

quality of peptides quantified based on MS1 XIC, drops to nearly 50% of MS2. There is

25–50% false positive quantification at the 0.5–1 fmol level peptides.

VGDANPALQK

FIGURE 3. MS2 Peak area as a function of mass load and their corresponding

variance per run for peptide VGDANPALQK. Inset: Expanded view of the

0.5 to 10 fmol level.

FIGURE 4. Peak profiles for

MS1 quantification (A, C, E)

profiles for peptide VGDANP

Insets (A) and (B) are expan

MS2 peak profiles, respectiv

(D) are expanded views of 0.

profiles, respectively, for pe

of probable isobaric contami

confidence, 10 fmol level qu

respectively, for peptide DM[

expanded view of peak profil

peptide at 10 fmol level.

MS1

A

C

E

G

Figures 4 and 5 demonstrate the increased confidence that is attained with real-time

state-modeled MS2 data quantification. The advantage of this acquisition scheme is

evident at levels of proteins and peptides below 10 fmol on column (or at signal

thresholds below 1 e

4

). There are cases in our study where both MS1 and MS2 do not

quantify a species; however, it is important to note that there are significantly fewer

false-positives with MS2 quantification.

isotope

nse isotope

e (min)

Stop time for “watch list”

Spectral

Library

Experimental

Spectrum